Oncology is different!







Xtandi is a good drug, but basically not ours. All credit goes to MDVN. We're doing everything possible to screw it up. Oncology group is drowning in the toxic Astellas culture, most original OSI folks have cashed in and left.
 












Oncology is a good place to be. Two very good drugs in highly competitive tumor types. Collaboration with MDV is very good. Every company has their good and bad. Bonus runs from 38-44 depending on your title